Related Experiment Video
Updated: May 31, 2025
Treatment with Vancomycin Loaded Calcium Sulphate and Autogenous Bone in an Improved Rabbit Model of Bone Infection
Published on: March 14, 2019
Oral vs Intravenous Antibiotics for Fracture-Related Infections: The POvIV Randomized Clinical Trial
, William T Obremskey1, Robert V O'Toole2
1Vanderbilt University Medical Center, Nashville, Tennessee.
Importance:
Fracture-related infection (FRI) is a serious complication following fracture fixation surgery. Current treatment of FRIs entails debridement and 6 weeks of intravenous (IV) antibiotics. Lab data and retrospective clinical studies support use of oral antibiotics, which are less expensive and may have fewer complications than IV antibiotics.
Objective:
To evaluate the effectiveness of treatment of FRI with oral vs IV antibiotics.
Design, Setting, And Participants:
The POvIV multicenter, prospective randomized clinical trial was conducted across 24 trauma centers in the US among patients aged 18 to 84 years who had fracture repair or arthrodesis with fixation with implants and developed an FRI without radiographic evidence of osteomyelitis. Patients were enrolled between March 2013 and September 2018 and followed up for 12 months after hospitalization for treatment of their FRI.
Intervention:
Oral vs IV antibiotics following FRI.
Main Outcomes And Measures:
The primary outcome was number of surgical interventions, and the primary hypothesis was noninferiority of oral vs IV antibiotics with respect to the number of study injury-related surgical interventions by 1 year. Unadjusted modified intent-to-treat (mITT) and adjusted per-protocol (PP) analyses were prespecified. A post hoc adjusted mITT analysis was conducted to resolve discrepancies between the results of the prespecified mITT and PP analyses. Recurrence of a deep surgical site infection was a key secondary outcome.
Results:
Among 233 total patients, mean (SD) age was 46.0 (13.9) years, and 53 patients were female (22.7%). The mean number of surgical interventions within 1 year was 1.3 and 1.1 for the oral and IV groups, respectively. The upper bound of the 95% confidence interval of the mean difference with unadjusted mITT analysis was 0.59, which was lower than the prespecified noninferiority margin of 0.67, indicating noninferiority of oral to IV antibiotics. Adjusted PP analysis did not support noninferiority of the number of reoperations. A post hoc adjusted mITT analysis also showed noninferiority. The treatment effects estimates for the key secondary outcome of reinfection showed a similar pattern as those for the primary outcome.
Conclusions And Relevance:
In this prospective randomized clinical trial, oral antibiotic treatment was noninferior to IV treatment with respect to the primary outcome of number of surgical interventions based on mITT analysis. However, there is some uncertainty in these findings based on preplanned and post hoc secondary analyses. A similar pattern of treatment effect estimates was observed for the secondary outcome of recurrence of infection.
Trial Registration:
ClinicalTrials.gov Identifier: NCT01714596.
Insights
Oral antibiotics were found to be noninferior to intravenous antibiotics for treating fracture-related infections (FRIs) in a multicenter trial. This suggests a potentially less expensive and safer treatment option for patients with FRIs.
Area of Science:
- Orthopedic Surgery
- Infectious Diseases
- Clinical Trials
Background:
- Fracture-related infection (FRI) is a significant complication after fracture fixation surgery.
- Current treatment involves debridement and 6 weeks of intravenous (IV) antibiotics.
- Oral antibiotics present a potentially less expensive and safer alternative.
Purpose of the Study:
- To compare the effectiveness of oral versus IV antibiotics for treating FRI.
- To evaluate noninferiority of oral antibiotics to IV antibiotics in terms of surgical interventions required.
Main Methods:
- A multicenter, prospective randomized clinical trial (POvIV) involving 233 patients.
- Patients received either oral or IV antibiotics for FRI treatment.
- Primary outcome: number of surgical interventions within 1 year; secondary outcome: recurrence of infection.
Main Results:
- Oral antibiotics were noninferior to IV antibiotics based on the primary outcome (number of surgical interventions) in the modified intent-to-treat (mITT) analysis.
- The upper bound of the confidence interval for the difference in surgical interventions was below the noninferiority margin.
- Secondary analyses, including per-protocol and post hoc mITT, showed some uncertainty, but a similar pattern for reinfection rates was observed.
Conclusions:
- Oral antibiotic treatment demonstrated noninferiority to IV treatment for FRI in the primary analysis.
- While secondary analyses indicated some uncertainty, the findings support oral antibiotics as a viable treatment option.
- Further investigation may be warranted to fully clarify the role of oral antibiotics in FRI management.
Related Concept Videos
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:26Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:27Fractures: Bone Repair
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
01:26Tonsillitis II: Management
01:22Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy